Recruiting Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778 Conditions Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more Locations David Geffen School of Medicine at the University of California at Los Angeles — Los Angeles, California, United States View Trial Details
Not Yet Recruiting Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma NCT07535710 Conditions Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more Locations Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai — Shanghai, China Ruijin Hospital Wuxi Branch — Wuxi, China View Trial Details
